Anjali Saqi, MD, MBA
Pathology - Anatomic & Clinical
Cytopathology
Accepting New Patients
On the web
Overview
Dr. Saqi is a Professor and Director of Pulmonary Pathology in the Department of Pathology & Cell Biology at Columbia University Medical Center. She is triple board certified and practices surgical pathology and cytopathology. Her primary interests are in pulmonary pathology and pancreatico-biliary cytopathology with a focus on maximizing results, including molecular diagnoses, on small samples. She is actively involved in teaching and conducting research with trainees and peers across multiple departments with primary interests in pulmonary-related collaborations. She also earned her MBA from Columbia Business School and applies her skills on entrepreneurial-related activities. Dr. Saqi has multiple pending and issued patents.
Email: aas177@cumc.columbia.edu
Areas of Expertise / Conditions Treated
- Pancreatobiliary Cytopathology
- Pulmonary Pathology
- Surgical Pathology
Academic Appointments
- Professor of Pathology & Cell Biology at CUMC
Administrative Titles
- Director, Pulmonary Pathology
Hospital Affiliations
- NewYork-Presbyterian / Columbia University Irving Medical Center
Gender
- Female
Schedule an Appointment
Connect Patient Portal
For existing patients, login to make an appointment, view documentation or contact your care provider.
Credentials & Experience
Education & Training
- State University of New York - Downstate Health Sciences Center
- MD, 1996 State University of New York Health Science Center at Brooklyn
- Internship: NewYork-Presbyterian Hospital/Weill Cornell Medical Center
- Residency: NewYork-Presbyterian Hospital/Weill Cornell Medical Center
- Residency: 2000 Weill Cornell Medical College
- Fellowship: Hospital of the University of Pennsylvania
- Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center
Board Certifications
- Pathology-Anatomic/Pathology-Clinical
- Cytopathology
Honors & Awards
- Karl Perzin Anatomic Pathology Faculty Teaching Award, Columbia University Medical Center 2024
- Castle Connolly Top Doctor 2016-2024
- Exceptional Women in Medicine 2019-2024
- Top AAPI Doctor 2023, 2024
America's Top Doctor
NY Top Doctor
Research
Anjali Saqi's research interests include mediastinal and pulmonary neoplastic and non-neoplastic diseases and Pancreaticobiliary cytology.
Clinical Trials
Dr. Saqi is a pathologist actively involved in clinical trials, including as a central reviewer and a participant on multiple committees. Most of the clinical trials focus on study of lung cancer resections following various neoadjuvant therapies.
Selected Publications
- Melms JC, Biermann J, Huang H, Wang Y, Nair A, Tagore S, Katsyv I, Rendeiro AF, Amin AD, Schapiro D, Frangieh CJ, Luoma AM, Filliol A, Fang Y, Ravichandran H, Clausi MG, Alba GA, Rogava M, Chen SW, Ho P, Montoro DT, Kornberg AE, Han AS, Bakhoum MF, Anandasabapathy N, Suárez-Fariñas M, Bakhoum SF, Bram Y, Borczuk A, Guo XV, Lefkowitch JH, Marboe C, Lagana SM, Del Portillo A, Zorn E, Markowitz GS, Schwabe RF, Schwartz RE, Elemento O, Saqi A, Hibshoosh H, Que J, Izar B. A molecular single-cell lung atlas of lethal COVID-19. Nature. 2021 Jul;595(7865):114-119. doi: 10.1038/s41586-021-03569-1. Epub 2021 Apr 29.
- Cimic A, Saqi A. Anal cytology and high-risk human papilloma virus testing in atypical squamous categories: Value of concurrent testing in management of high-risk population. Diagn Cytopathol. 2021 Jun;49(6):793-798. doi: 10.1002/dc.24740. Epub 2021 Apr 19.
- Szabo PA, Dogra P, Gray JI, Wells SB, Connors TJ, Weisberg SP, Krupska I, Matsumoto R, Poon MML, Idzikowski E, Morris SE, Pasin C, Yates AJ, Ku A, Chait M, Davis-Porada J, Guo XV, Zhou J, Steinle M, Mackay S, Saqi A, Baldwin MR, Sims PA, Farber DL. Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19. Immunity. 2021 Apr 13;54(4):797-814.e6. doi: 10.1016/j.immuni.2021.03.005. Epub 2021 Mar 11.
- May MS, Kinslow CJ, Adams C, Saqi A, Shu CA, Chaudhary KR, Wang TJC, Cheng SK. Outcomes for localized treatment of large cell neuroendocrine carcinoma of the lung in the United States. Transl Lung Cancer Res. 2021 Jan;10(1):71-79. doi: 10.21037/tlcr-20-374.
- Shirsat H, Zhou F, Chang JC, Rekhtman N, Saqi A, Argyropoulos K, Azour L, Simms A, Melamed J, Hung YP, Roden AC, Mino-Kenudson M, Moreira AL, Narula N. Bronchiolar Adenoma/Pulmonary Ciliated Muconodular Papillary Tumor. Am J Clin Pathol. 2021 May 18;155(6):832-844. doi: 10.1093/ajcp/aqaa194.
- Kunnath-Velayudhan S, Larsen BT, Coley SM, De Michele S, Santoriello D, Colby TV, Bhagat G, Saqi A. Masson Trichrome and Sulfated Alcian Blue Stains Distinguish Light Chain Deposition Disease From Amyloidosis in the Lung. Am J Surg Pathol. 2021 Mar 1;45(3):405-413. doi: 10.1097/PAS.0000000000001593.
- De Michele S, Remotti HE, Del Portillo A, Lagana SM, Szabolcs M, Saqi A. SATB2 in Neoplasms of Lung, Pancreatobiliary, and Gastrointestinal Origins. Am J Clin Pathol. 2021 Jan 4;155(1):124-132. doi: 10.1093/ajcp/aqaa118.
- Maniar R, Anderson M, Taback B, Khan S, McDonnell D, Saqi A, Niedt GW, Carvajal R. Case of Merkel cell carcinoma in a patient with pre-existing ILD. J Immunother Cancer. 2020 Nov;8(2):e001672. doi: 10.1136/jitc-2020-001672.
- Szabo PA, Dogra P, Gray JI, Wells SB, Connors TJ, Weisberg SP, Krupska I, Matsumoto R, Poon MML, Idzikowski E, Morris SE, Pasin C, Yates AJ, Ku A, Chait M, Davis-Porada J, Zhou J, Steinle M, Mackay S, Saqi A, Baldwin M, Sims PA, Farber DL. Analysis of respiratory and systemic immune responses in COVID-19 reveals mechanisms of disease pathogenesis. medRxiv. 2020 Oct 18:2020.10.15.20208041. doi: 10.1101/2020.10.15.20208041. Preprint.
For a complete list of publications, please visit PubMed.gov